Morgan Stanley’s Entera Bio ENTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,000
| Closed | -$1.2K | – | 7865 |
|
|
2023
Q4 | $1.2K | Buy |
2,000
+1,000
| +100% | +$600 | ﹤0.01% | 7186 |
|
|
2023
Q3 | $725 | Sell |
1,000
-100
| -9% | -$73 | ﹤0.01% | 7271 |
|
|
2023
Q2 | $928 | Buy |
1,100
+100
| +10% | +$84 | ﹤0.01% | 7306 |
|
|
2023
Q1 | $1.16K | Hold |
1,000
| – | – | ﹤0.01% | 7330 |
|
|
2022
Q4 | $730 | Sell |
1,000
-35,166
| -97% | -$25.7K | ﹤0.01% | 7518 |
|
|
2022
Q3 | $38K | Buy |
36,166
+33,400
| +1,208% | +$35.1K | ﹤0.01% | 6529 |
|
|
2022
Q2 | $4K | Sell |
2,766
-2,190
| -44% | -$3.17K | ﹤0.01% | 7444 |
|
|
2022
Q1 | $14K | Sell |
4,956
-1,012
| -17% | -$2.86K | ﹤0.01% | 7280 |
|
|
2021
Q4 | $17K | Buy |
5,968
+590
| +11% | +$1.68K | ﹤0.01% | 7274 |
|
|
2021
Q3 | $25K | Buy |
5,378
+3,188
| +146% | +$14.8K | ﹤0.01% | 7011 |
|
|
2021
Q2 | $13K | Buy |
+2,190
| New | +$13K | ﹤0.01% | 7151 |
|